Open AccessWhy the results of adjuvant pertuzumab in HER2-positive early breast cancer has been received as a mitigate success?
Author(s) -
Xavier Pivot,
David G. Cox,
Joseph Gligorov
Publication year - 2018
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2017.10.07
Subject(s) - pertuzumab , medicine , adjuvant , breast cancer , oncology , trastuzumab , cancer